Prostate Cancer Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- You must be male
- You must be 18 years of age or older
- You must have been diagnosed with prostate cancer (a specific type called adenocarcinoma, confirmed by a tissue test)
- Your prostate cancer must not have spread to other parts of the body
- You must be planning to have your prostate surgically removed at Massachusetts General Hospital
Who may not be able to join:
- You must not have already received radiation therapy, hormone therapy, or any other medical treatment for your prostate cancer before surgery (treatment after surgery is allowed)
- You must not have prostate cancer that has spread to other parts of the body
- You must not have a current or previous diagnosis of any other cancer that affects body tissues, with the exception of certain skin cancers (such as squamous cell carcinoma or basal cell carcinoma)
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Richard J. Lee, MD, PhD, Massachusetts General Hospital
Phone: 617-724-4000
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Relationship between CTC quantity and pathologic stage; Persistent CTC and biochemical recurrence
Can't join this trial?
Data last synced from ClinicalTrials.gov: 23 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.